Dwight Fitzgerald Matthias, MD
NPI 1609805332ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Newport News, VA
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Newport News, Virginia, licensed in VA and CA, with an NPI issued in July 2006. Their prescriptions cost Medicare Part D more than their services did: $1,737,285 for 3,889 claims, against $109,274 paid for services in 2024. Amgen Inc. was the largest of 16 companies reporting payments in 2025, $701.57 in all, mostly food and beverage. Lists Chesapeake General Hospital and 4 other hospitals as hospital affiliations.
Overview
| NPI | 1609805332 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jul 3, 2006 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 0101229098 | VA |
| Internal Medicine, Endocrinology, Diabetes & Metabolism | 207RE0101X | A63168 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (VA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 521 |
|---|---|
| Services billed | 1,427 across 5 procedure codes |
| Paid by Medicare | $109,274 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,889 · 9,277 30-day fills |
|---|---|
| Patients | 422 |
| Total drug cost | $1,737,285 |
| Generic share | 42% of claims |
Education and affiliations
| Graduation year | 1992 |
|---|---|
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
Hospital affiliations
- Chesapeake General HospitalChesapeake, VA
- Riverside Regional Medical CenterNewport News, VA
- Riverside Walter Reed HospitalGloucester, VA
- Sentara Norfolk General HospitalNorfolk, VA
- The Outer Banks Hospital, IncNags Head, NC
Industry payments (Open Payments)
- 2025$701.57 · 28 payments from 16 companies
- 2024$377.72 · 17 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Amgen Inc. | $148.56 | 3 |
| Medtronic, Inc. | $109.36 | 1 |
| Novo Nordisk Inc | $76.62 | 3 |
| Ascendis Pharma Endocrinology Inc | $53.20 | 3 |
| Corcept Therapeutics | $47.53 | 2 |
What the 2025 payments were for
- Food and Beverage$645.26 · 26 payments
- Education$56.31 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Newport News
- 1356363949
- 1003888264
- 1851489124
- 1881782233
- 1740472646
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Virginia →